Efficacy and Safety of MSLN CAR-T in Advanced Malignant Tumors
NCT07399769
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Advanced Solid Malignant Tumors (With Positive Expression of MSLN in Tumor Tissue)
Interventions
COMBINATION_PRODUCT:
CAR-T
Sponsor
Shenzhen University General Hospital